4
Changes in Ownership
Organogenesis Holdings Inc. Filed Acc 0001062993-22-018718
Chief Commercial Officer acquired 805 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Grow Brian Chief Commercial Officer | 2022-08-20 | Option exercise | +805 | $1.46 | $1,175 | 87,744 | D |
| Derivatives | |||||||
| Grow Brian Chief Commercial Officer | 2022-08-20 | Option exercise · Stock Option (Right to Buy) | −805 | 0 | D | ||
Loading xslF345X03/form4.xml…